JOURNAL OF CHEMOTHERAPY

简称 J CHEMOTHERAPY ·ITALY ·出版周期 Bimonthly ·年均收录 82 篇

1.8

最新影响因子

2.00%

自引率

容易

投稿难度

较慢,6-12周

审稿周期

期刊简介

JOURNAL OF CHEMOTHERAPY是一本国际学术期刊，ISSN号为1120-009X，由意大利的EDITRICE ESERVIZI SRL出版，出版地为意大利，出版周期为双月刊。该期刊的影响因子根据年份不同有所波动，具体数值需查阅最新数据。它目前被SCI收录，属于中科院分区的某一类别（具体分区需根据最新中科院分区表确认），但并非完全开放获取（OA）期刊。该杂志主要聚焦于化疗领域的研究，涵盖抗菌药物、抗肿瘤药物、耐药性机制、药物开发及临床治疗等方面的内容，尤其关注多学科交叉研究和临床实践应用。其发文特点包括发表原创研究论文、综述和病例报告，注重实验与临床结合的研究成果。杂志的质量较高，审稿流程严格，但需注意其影响因子和分区可能随年度变化而波动，投稿前建议核实最新数据以评估潜在风险。

影响因子趋势

近期发表

Longitudinal acquisition and infection risk associated with multidrug-resistant organisms and Candida colonization in intensive care unit patients 2026-09-12

Circular RNAs: key regulators and mechanistic insights in breast cancer drug resistance 2026-09-10

Tumor resistance to protein kinase inhibitors 2026-09-10

First-line therapy and maintenance outcomes in Chinese patients with marginal zone lymphoma: a multicenter retrospective analysis with prognostic implications for chemotherapy decision-making 2026-09-06

The epigenetic regulator ALKBH5 facilitates the early adaptation of hepatocellular carcinoma cells to sorafenib treatment 2026-09-03

Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy 2026-09-01

The emerging trends in prostate cancer treatment: a systematic review of the literature 2026-08-21

Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis 2026-08-16

Pharmacogenomic biomarkers in oncology: evidence, clinical utility, and barriers to implementation 2026-08-06

Clinical efficacy and safety profile of long-acting lipoglycopeptides versus daily intravenous antibiotics for acute bacterial skin and skin structure infections (ABSSSI): a retrospective study in Greece 2026-08-03